Concepedia

Time to biochemical failure and prostate-specific antigen doubling time as surrogates for prostate cancer-specific mortality: evidence from the TROG 96.01 randomised controlled trial

James W. Denham, Allison Steigler, Chantelle Wilcox, David S. Lamb, David Joseph, Chris Atkinson, John Matthews, Keen‐Hun Tai, Nigel Spry, David Christie,

The Lancet Oncology · 2008 · 96 citations · 30 references

References

30

Regression Models and Life-Tables

D. R. Cox · Journal of the Royal Statistical Society Series B (Statistical Methodology) · 1972 · 39.3K citations · Full text

Public Health, Biostatistics, Hazard Identification +16

Nonparametric Estimation from Incomplete Observations

Edward L. Kaplan, Paul Meier · Journal of the American Statistical Association · 1958 · 39.1K citations

Public Health, Biostatistics, Mathematics +10

Natural History of Progression After PSA Elevation Following Radical Prostatectomy

Charles R. Pound · JAMA · 1999 · 3.1K citations

Medicine, Surgery, Urology +7

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference

Mack Roach, Gerald E. Hanks, Howard D. Thames et al. · International Journal of Radiation Oncology*Biology*Physics · 2006 · 2.7K citations

Medicine, Radiation Oncology, Urology +14

Surrogate endpoints in clinical trials: Definition and operational criteria

Ross L. Prentice · Statistics in Medicine · 1989 · 2K citations

Medicine, Biostatistics, Comparative Effectiveness Research +14